Search results
Results from the WOW.Com Content Network
Treatments with iron(II) sulfate have higher incidence of adverse events than iron(III)-hydroxide polymaltose complex (IPC) [29] [30] [31] or iron bis-glycinate chelate. [32] [33] Iron overdose has been one of the leading causes of death caused by toxicological agents in children younger than six years. [34] Iron poisoning may result in ...
For premium support please call: 800-290-4726 more ways to reach us
Iron chelate is commonly used for agricultural purposes to treat chlorosis, a condition in which leaves produce insufficient chlorophyll. Iron and ligand are absorbed separately by the plant roots whereby the highly stable ferric chelate is first reduced to the less stable ferrous chelate. [ 6 ]
Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations.The preparation is a macromolecular complex, consisting of iron(III) hydroxide (trivalent iron, Fe 3+, Fe(OH) 3 ·H 2 O) and the carrier polymaltose and is available in solid form as a film-coated or chewable tablet and in liquid form ...
An analysis of data from more than 8,000 adults in the U.S. revealed that 14% had low iron blood levels, a condition known as absolute iron deficiency, while 15% had the right iron levels but ...
A new study shows nearly 1 in 3 adults in the United States may have iron deficiency. Whether through food or supplements, there are healthy ways to get more iron in your diet without relying on ...
[1] [2] Overdoses on iron can be categorized as unintentional ingestion which is predominantly associated with children or intentional ingestion involving suicide attempts in adults. [3] Unintentional ingestion of iron containing drug products are a major cause of mortality in children under the age of 6 years old in the United States. [3]
Iron-deficiency anemia is anemia caused by a lack of iron. [3] Anemia is defined as a decrease in the number of red blood cells or the amount of hemoglobin in the blood. [3] When onset is slow, symptoms are often vague such as feeling tired, weak, short of breath, or having decreased ability to exercise. [1]